Victory Capital Management
STOK icon

Victory Capital Management’s Stoke Therapeutics STOK Stock Holding History

Victory Capital Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
44,900
+11,010
+32% +$353K ﹤0.01% 1734
2026
Q1 		$1.1M Sell
33,890
-7,250
-18% -$238K ﹤0.01% 1799
2025
Q4 		$1.31M Buy
+41,140
New +$1.24M ﹤0.01% 1707
2023
Q1 		– Sell
-18,581
Closed -$172K – 2687
2022
Q4 		$172K Sell
18,581
-1,217
-6% -$12.7K ﹤0.01% 2289
2022
Q3 		$254K Sell
19,798
-1,233
-6% -$19.6K ﹤0.01% 2298
2022
Q2 		$278K Buy
21,031
+807
+4% +$12.3K ﹤0.01% 2261
2022
Q1 		$292K Sell
20,224
-45,947
-69% -$920K ﹤0.01% 2307
2021
Q4 		$1.59M Buy
66,171
+12,689
+24% +$303K ﹤0.01% 1642
2021
Q3 		$1.36M Sell
53,482
-4,956
-8% -$138K ﹤0.01% 1722
2021
Q2 		$1.97M Sell
58,438
-3,421
-6% -$121K ﹤0.01% 1638
2021
Q1 		$2.4M Sell
61,859
-15,069
-20% -$858K ﹤0.01% 1595
2020
Q4 		$4.76M Buy
76,928
+9,352
+14% +$429K 0.01% 1255
2020
Q3 		$2.26M Sell
67,576
-9,686
-13% -$277K ﹤0.01% 1406
2020
Q2 		$1.84M Sell
77,262
-125,301
-62% -$2.97M ﹤0.01% 1466
2020
Q1 		$4.64M Buy
202,563
+22,915
+13% +$566K 0.01% 1107
2019
Q4 		$5.09M Buy
179,648
+175,735
+4,491% +$4.42M 0.01% 1183
2019
Q3 		$84K Buy
3,913
+1,413
+57% +$39.4K ﹤0.01% 2491
2019
Q2 		$73K Buy
+2,500
New +$67.1K ﹤0.01% 1679

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management's STOK Position: Q2 2026 in Review

Victory Capital Management increased its Stoke Therapeutics (STOK) stake by 32% in Q2 2026, buying an estimated $353K and bringing the position to 44,900 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Victory Capital Management first reported a position in STOK in Q2 2019 and has held it in 18 quarters since. The position peaked at $5.09M in Q4 2019. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Victory Capital Management held 44,900 shares of Stoke Therapeutics worth $1.47M as of Q2 2026.
  • Victory Capital Management bought 11,010 Stoke Therapeutics shares in Q2 2026, an estimated $353K.
  • Stoke Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1734 holding.
  • Victory Capital Management first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 18 quarters since.
  • Victory Capital Management's Stoke Therapeutics position peaked at $5.09M in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.